IP and R&D Tax Credits: Getting it Right from the Start

If you are an emerging (bio)pharma company leader, take the opportunity to share your thoughts and concerns around building an investable IP position. Investors and big pharma expect a lot of prep work from pharma and biotech companies so they can evaluate the current status of a target and assess the route to recoup any investment. This roundtable event aims to give an interactive summary of the key points to achieve commercial success by building a strong and attractive IP position.